The pathophysiology and management of diuretic resistance in patients with heart failure
- PMID: 33596757
- DOI: 10.1080/21548331.2021.1893065
The pathophysiology and management of diuretic resistance in patients with heart failure
Abstract
Objectives: The objectives of the study are to investigate the causes of diuretic resistance in patients with advanced congestive heart failure (CHF), since diuretics are the cornerstone of treatment of these patients. Several studies have shown that diuretic resistance in patients with advanced CHF is common, ranging from 25% to 50% in hospitalized patients.
Methods: In order to get a current perspective as to the magnitude of diuretic resistance in such patients, a focused Medline search of the English language literature was conducted between 2015 and 2020 using the search terms, CHF, diuretics, treatment, resistance, frequency, and 30 papers with pertinent information were selected.
Results: The analysis of data from the selected papers demonstrated that diuretic resistance is common in hospitalized patients with advanced CHF and frequently associated with renal failure, which is secondary to CHF.
Conclusions: Diuretic resistance appears to be common in patients with advanced CHF and it is mostly due to decreased cardiac output, low blood pressure, decreased glomerular filtration rate, decreased filtration of sodium, and increased tubular reabsorption of sodium. Diuretic resistance in such patients can be overcome with the combination of loop diuretics with thiazide and thiazide-like diuretics, aldosterone antagonists, as well as other agents. The data from these studies in combination with collateral literature will be discussed in this review.
Keywords: Congestive heart failure; diuretic combinations; diuretics; renal failure; resistance; treatment.
Similar articles
-
[Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].Herz. 2002 Mar;27(2):135-49. doi: 10.1007/s00059-002-2352-0. Herz. 2002. PMID: 12025459 Review. German.
-
Combination diuretic therapy in severe congestive heart failure.Drugs. 1998 Feb;55(2):165-72. doi: 10.2165/00003495-199855020-00001. Drugs. 1998. PMID: 9506239 Review.
-
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18. Minerva Cardioangiol. 2011. PMID: 21330961
-
Diuretics in renal failure.Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):32-8. doi: 10.1159/000057416. Miner Electrolyte Metab. 1999. PMID: 10207256 Review.
-
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.Am J Physiol Renal Physiol. 2003 May;284(5):F1115-9. doi: 10.1152/ajprenal.00337.2002. Am J Physiol Renal Physiol. 2003. PMID: 12676739 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical